efaproxiral has been researched along with Cardiac Failure in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Aki-Jin, Y; Higuchi, Y; Hikoso, S; Hori, M; Imai, K; Matsumura, Y; Mizote, I; Nakai, A; Nakano, Y; Nishida, K; Omiya, S; Otsu, K; Shimizu, T; Shirasawa, T; Takeda, T; Taniike, M; Watanabe, T; Yamaguchi, O | 1 |
1 other study(ies) available for efaproxiral and Cardiac Failure
| Article | Year |
|---|---|
Reduction in hemoglobin-oxygen affinity results in the improvement of exercise capacity in mice with chronic heart failure.
Topics: Aniline Compounds; Animals; Antisickling Agents; Exercise Tolerance; Globins; Heart Failure; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Oxygen Consumption; Propionates | 2008 |